Clinical Trial

Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction and safety.
Trial Details
NCT Number NCT06618079
Lead Sponsor Huons Co., Ltd.
Conditions Hypertension
Enrollment 46 participants
Start Date 2024-04-20
Primary Completion 2024-07-12 (estimated)
Study Completion 2024-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-01